CAFs interact with mesenchymal glioblastoma stem cells (GSCs) and M2 macrophages, promoting tumor growth via PDGF, TGF-β, osteopontin, and HGF signaling, making them a potential therapeutic target (Jain et al., 2023). This evidence concerns the gene TGFB1 and neoplasm.